MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Movement Disorder Fellowships: Assessment and Recruitment Strategies to Meet Clinical Needs

    M. Rashid, A. Zafar, J. Owens, G. Patino, M. Robbins, S. Sandrone, H. Sarva (Ottawa Hills, USA)

    Objective: 1. Identify factors leading to lower number of residents interested in movement disorders fellowship. 2. Propose strategies to increase recruitment. Background: The prevalence of…
  • MDS Virtual Congress 2021

    Longitudinal healthcare utilization and costs in Parkinson disease : from pre-diagnosis to 9 years

    S. Neo, E. Soh, A. Wong, W. Li, HL. Ng, KY. Tay, WL. Au, L. Tan (Singapore, Singapore)

    Objective: The aim of this study was to characterize attributable healthcare utilization and costs in Parkinson disease (PD) in newly diagnosed PD patients managed by…
  • MDS Virtual Congress 2021

    Neuropsychiatric evaluation in patients with functionel movements disorders

    M. Balal, S. çakmak, M. Demirkiran (Adana, Turkey)

    Objective: The aim of this study is to investigate the neuropsychiatric evaluations in patients with functional movement disorders. Background: Functional movement disorders include a group…
  • MDS Virtual Congress 2021

    Cognitive profiling in a cohort of Primary Familial Brain Calcification (PFBC) patients

    M. Garon, M. Carecchio, L. Weis, F. Pistonesi, M. Mainardi, G. Bonato, L. Salviati, A. Antonini, R. Biundo (Padova, Italy)

    Objective: To investigate neuropsychological and behavioural profile of PFBC patients. Background: PFBC is a rare genetic neurodegenerative disorder characterized by abnormal calcium phosphate deposition basal…
  • MDS Virtual Congress 2021

    Evolving inclusion criteria in early manifest Huntington’s disease (HD) to address striatal atrophy: Lessons from HD-GeneTRX-1, the first gene therapy trial

    E. Furr-Stimming, C. Testa, P. Larson, C. Ross, R. Lonser, A. Samii, D. Cooper, S. Ying, M. Clarkin, E. Sawyer, R. Reilmann (Houston, USA)

    Objective: To describe the early screening experience and evidence-based adaptations to the inclusion criteria for HD-GeneTRX-1 (NCT04120493). Background: AMT-130 is an AAV5-based gene therapy intended…
  • MDS Virtual Congress 2021

    Nonmotor Symptoms in Huntington disease in relation to the Diagnostic Confidence Level

    N. Rocha, M. Edmondson, C. Testa, J. Patino, M. Rossetti, A. Teixeira, E. Furr Stimming (Houston, USA)

    Objective: To analyze HD gene carriers’ performance on cognitive and behavioral tests according to the Diagnostic Confidence Level (DCL). Background: The diagnosis of manifest HD…
  • MDS Virtual Congress 2021

    Progressive Ataxia with Palatal Tremor in a Metal Worker with Possible Osmotic Demyelination

    I. Goldszer, S. Merchant (Charleston, USA)

    Objective: We present the case of a 40 year old male alcoholic metal worker with 3 years of progressive ataxia of gait and palatal tremor. …
  • MDS Virtual Congress 2021

    An Eye of a Tiger cannot see all the true: a case series.

    I. Teixeira, S. Trivellato, I. Fonseca, D. Margato, R. Bazan, A. Schelp (Botucatu, Brazil)

    Objective: Describe patients with Multiple System Atrophy with iron accumulation in neuroimaging of striatal regions. Background: MSA is an adult neurodegenerative disease with parkinsonism, cerebelar…
  • MDS Virtual Congress 2021

    Promising Biomarkers for Task Specific Dystonia

    S. Merchant, M. Hallett (Charleston, USA)

    Objective: To test the sensitivity, specificity, reproducibility and reliability of two neurophysiologic variables using transcranial magnetic stimulation (TMS) as potential diagnostic biomarkers of task specific…
  • MDS Virtual Congress 2021

    Movement Disorders in Subacute Sclerosing Panencephalitis Patients

    C. Rawat, S. Pandey (New Delhi, India)

    Objective: We aimed to study the frequency of movement Disorders other than myoclonus seen in patients with subacute sclerosing panencephalitis (SSPE). Background: SSPE is a…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley